Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network
HIV Medicine · 2026-11 · 27 (11) · 1814-1822
DOI: 10.1111/hiv.70303 ↗Kurz gefasst
Fachartikel in der Zeitschrift HIV Medicine, online erschienen am 22.09.2026. Verfasst von Richard Elion und 10 weiteren Autor:innen. Beteiligte Einrichtung: Analytics, Trio Health, Louisville, Colorado, USA. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Piperazines, Organophosphates. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: ViiV Healthcare.
Abstract (Originalsprache)
Objective
To describe real‐world patterns of use, virologic and immunologic outcomes and treatment persistence among people with HIV (PWH) initiating fostemsavir (FTR) in a diverse US cohort.
Design
Retrospective cohort study of adults receiving FTR in clinical practice, stratified by baseline viral suppression status.
Methods
Adults with ≥1 FTR prescription between July 2020 and August 2023 were included and followed for 12 months. Individuals with trial participation were excluded. Outcomes included virologic suppression (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Analytics, Trio Health, Louisville, Colorado, USA.
- Epidemiology and Real World Evidence, Viiv Healthcare, Durham, North Carolina, USA.
- Infectious Disease, Midway Immunology and Research Center, Fort Pierce, Florida, USA.
- Care Resource, Miami, Florida, USA.
- School of Medicine at the University of Pennsylvania, Philadelphia Fight Community Health Centers, Philadelphia, Pennsylvania, USA.
- Ruth M. Rothstein CORE Center, Rush University Medical Center, Chicago, Illinois, USA.
ORCID-Profile: Cassidy Henegar, Isobel McEwen, Andrew Frick, Moti Ramgopal, Vani Vannappagari
Förderung
- ViiV Healthcare
Zitieren
APA
Elion, R., Henegar, C., McEwen, I., Frick, A., Ramgopal, M., Santiago, S., Mounzer, K., Huhn, G., Walworth, C., Ragone, L., & Vannappagari, V. (2026). Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network. HIV Medicine, 27(11), 1814-1822. https://doi.org/10.1111/hiv.70303
Vancouver
Elion R, Henegar C, McEwen I, Frick A, Ramgopal M, Santiago S, et al. Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network. HIV Medicine. 2026;27(11):1814-1822. doi:10.1111/hiv.70303
BibTeX
@article{Elion2026,
author = {Elion, Richard and Henegar, Cassidy and McEwen, Isobel and Frick, Andrew and Ramgopal, Moti and Santiago, Steven and Mounzer, Karam and Huhn, Gregory and Walworth, Charles and Ragone, Leigh and Vannappagari, Vani},
title = {Real‐world use and effectiveness of fostemsavir in a US clinical setting: Insights from Trio Health HIV Research Network},
journal = {HIV Medicine},
year = {2026},
volume = {27},
number = {11},
pages = {1814--1822},
doi = {10.1111/hiv.70303}
}
EUVIMED